| abstract |
Formula (I) 1-phenyl 1-thio-D-glucitol compound represented by the above or a pharmaceutically acceptable salt thereof or a hydrate thereof, or a medicament containing these as an active ingredient is SGLT1 and SGLT2. It is useful as a preventive or therapeutic agent for a new type of diabetes, diabetes-related diseases or diabetic complications that inhibits both activities and has both glucose absorption suppression from the digestive tract and urinary glucose excretion. |